alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6704 Introduced in House (IH)]

<DOC>

117th CONGRESS
  2d Session
                                H. R. 6704

   To prohibit the use of Federal funds to purchase, or support the 
                    purchase of, drug paraphernalia.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 11, 2022

Mr. Bishop of North Carolina (for himself, Mrs. Boebert, Mr. Biggs, Mr. 
  Duncan, Mr. Hice of Georgia, Mr. Gaetz, Mr. Posey, Mr. Steube, Ms. 
    Herrell, Mr. Webster of Florida, and Mr. Perry) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL

 
   To prohibit the use of Federal funds to purchase, or support the 
                    purchase of, drug paraphernalia.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Halting the Use of Narcotics Through 
Effective Recovery Act of 2022'' or the ``HUNTER Act of 2022''.

SEC. 2. PROHIBITION AGAINST USE OF FEDERAL FUNDS FOR DRUG 
              PARAPHERNALIA.

    (a) In General.--No Federal funds, including funds appropriated by 
section 2706 of the American Rescue Plan Act of 2021 (42 U.S.C. 290dd-3 
note), may be used for the purchase, or to support the purchase by any 
recipient of Federal assistance, of any drug paraphernalia.
    (b) Definition.--In this section, the term ``drug paraphernalia''--
            (1) has the definition given to that term in section 863 of 
        title 18, United States Code; and
            (2) includes, to the extent covered by such definition, 
        crack pipes, harm reduction vending machines, syringes, and 
        safe smoking kits and supplies.
                                 <all>
```
The Hono rable Elsijane T. Roy, United States District Judge for the Easter n 1 District of Arkansas. 

## United States Court of Appeals FOR THE EIGHTH CIRCUIT

___________ No. 98-2240

___________ LaVerne G. Rens, parent and next * friend of L.R., a minor, * * Appellant, * * v. * Appeal from the United States * District Court for the Arkansas Department of Education; * Eastern District of Arkansas Little Rock School District, * * [UNPUBLISHED] Appellees. *

___________ Submitted: November 17, 1998 Filed: January 7, 1999

___________ Befo re McMILLIAN, RICHARD S. ARNOLD, and MORRIS SHEPPAR D ARNOLD, Circuit Judges.

___________ PER CURIAM. LaVerne G. Rens appeals fr om the final judgment entered in the District Court 1 forthe Eastern District of Arkansas dismissing his claims against the Arkansa s Department of Education and the Little Rock School District in this action brough t under the Individuals with Disabilities Education Act (IDEA), 20 U.S.C. §§ 1400-1491-2-

(1990 & Supp. 1997). Upon a thorough review of the record and the parties’ briefs, we conclude that dismissal w as warranted, because Rens’s complaint alleges no more than a harmless procedural violation of th e IDEA. Because we believe that an opinion wouldlack precedential value, we summarily affirm the judgment. See 8th Cir. R
. 47B. A true copy.

Attest: CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
#### Lynard G. WILLIAMS, Plaintiff-Appellant, v. PPG INDUSTRIES, INCORPORATED, Defendant-Appellee.

No. 02-1882.

United States Court of Appeals, Fourth Circuit.

Submitted Oct. 24, 2002.

Decided Nov. 7, 2002.

Lynard G. Williams, Appellant Pro Se. Karin Marie McGinnis, Nicole Lee Gardner, Moore *&*Van Allen, Charlotte, North Carolina, for Appellee.

Before WILKINS, LUTTIG, and TRAXLER, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

PER CURIAM.

Lynard G. Williams appeals the magistrate judge’s order granting summary judgment to his employer and dismissing his employment discrimination action. We have reviewed the record and the magistrate judge’s opinion and find no reversible error. Accordingly, we affirm on the reasoning of the magistrate judge.**See Williams v. PPG Indus., Inc.,*No. CA-01-459 (M.D.N.C. July 17, 2002). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*

*

 The parties consented to the jurisdiction of the magistrate judge pursuant to 28 U.S.C. § 636(c) (2000).
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Small Business Administration

          - [License No. 09/79-0454] 

Notice is hereby given that Emergence Capital Partners SBIC, L.P., 160 Bovet Road, Suite 300, San Mateo, CA 94402, a Federal Licensee under the Small Business Investment Act of 1958, as amended (“the Act”), in connection with the financing of a small concern, has sought an exemption under Section 312 of the Act and Section 107.730, Financings which Constitute Conflicts of Interest of the Small Business Administration (“SBA”) Rules and Regulations (13 CFR 107.730). Emergence Capital Partners SBIC, L.P. proposes to provide equity/debt security financing to Krugle, Inc., 200 Middlefield Road, Suite 104, Menlo Park, CA 94025. 

The financing is brought within the purview of § 107.730(a)(1) of the Regulations because Emergence Capital Partners, L.P. and Emergence Capital Associates, L.P., all Associates of Emergence Capital Partners SBIC, L.P., own more than ten percent of Krugle, Inc., and therefore this transaction is considered a financing of an Associate requiring prior SBA approval. 

Notice is hereby given that any interested person may submit written comments on the transaction, within fifteen days of the date of this publication, to the Associate Administrator for Investment, U.S. Small Business Administration, 409 Third Street, SW., Washington, DC 20416. 

August 11, 2008. 

A. Joseph Shepard, 

Associate Administrator for Investment.

[FR Doc. E8-20125 Filed 8-28-08; 8:45 am] 

BILLING CODE 8025-01-P
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

NO. 03-11-00591-CV

In re Paul Douglas Archer

ORIGINAL PROCEEDING FROM COMAL COUNTY

M E M O R A N D U M O P I N I O N

Relator Paul Douglas Archer, an inmate convicted of the offenses of indecency with

a child and aggravated sexual assault, has filed a pro se petition for writ of mandamus against the 1

Sheriff of Comal County and the chief civil legal assistant of the Comal County District Attorney’s

Office. The petition alleges that respondents have refused to provide information requested

by relator under the Texas Public Information Act. See Tex. Gov’t Code Ann. §§ 552.001-.353

(West 2004 & Supp. 2010).

This Court’s mandamus jurisdiction is limited. We have jurisdiction to issue awrit of

mandamus against district or county court judges in our district. See id. § 22.221(b) (West 2004).

We do not have mandamus jurisdiction against other individuals unless issuance of the writ is

necessary to enforce this Court’s jurisdiction. See id. § 22.221(a); see also Silva v. Klevenhagen,

833 S.W.2d 746, 747 (Tex. App.—Houston [1st Dist.] 1992, orig. proceeding). Relator has not

See Archer v. State, Nos. 03-07-00019-CR & 03-07-00020-CR, 2007 Tex. App. LEXIS

1

6612 (Tex. App.—Austin Aug. 17, 2007, pet. ref’d, untimely filed) (mem. op., not designated for

publication).
demonstrated, and we do not conclude, that the requested relief is necessary to enforce our

jurisdiction.

The petition for writ of mandamus is denied. See Tex. R. App. P. 52.8(a).

__________________________________________

Bob Pemberton, Justice

Before Chief Justice Jones, Justices Pemberton and Henson

Filed: October 19, 2011

2
SENTRY PETROLEUM LTD. 
SHARE OPTION PLAN 
February 28, 2009



OPTION COMMITMENT



Notice is hereby given that, effective this 28th day of February, 2009 (the Effective Date) SENTRY PETROLEUM LTD. (the Company) has granted to Arne Raabe, an Option to acquire 150,000 Common Shares (Optioned Shares) up to 5:00 p.m. Pacific time on the 28th day of February, 2014 (the Expiry Date) at a Exercise Price of US$1.04 per share. Optioned Shares may be acquired as follows:

| |     |                                                                                                               
| | --- | --------------------------------------------------------------------------------------------------------------
| | (a) | 1/3 of the total number of Optioned Shares granted will vest twelve months after the Effective Date;          
| |     |                                                                                                               
| | (b) | a further 1/3 of the total number of Optioned Shares granted will vest 24 months after the Effective Date; and
| |     |                                                                                                               
| | (c) | the remaining 1/3 of the total number of Optioned Shares granted will vest 36 months after the Effective Date.

The grant of the Optioned Shares evidenced hereby is made subject to the terms and conditions of the Companys Share Option Plan, the terms and conditions of which are hereby incorporated in this Option Commitment.

To exercise your Option, deliver to the Company at its then principal business office, a written notice specifying the number of Optioned Shares you wish to acquire, together with cash or a certified cheque payable to the Company for the aggregate Exercise Price. A certificate for the Optioned Shares so acquired will be issued by the transfer agent as soon as practicable thereafter and will bear a legend stipulating any resale restrictions required under applicable securities laws.



SENTRY PETROLEUM LTD.

President

I hereby acknowledge receipt of a copy of the Plan and agree to be bound by the terms of the Plan. This commitment supersedes any prior Option or commitment made to me.



OPTIONEE

ARNE RAABE_______________________________

Name:       
__Arne Raabe_______________________

Address:    ___________________________________

___________________________________







---
<PAGE>


                                                                  Exhibit 12 (a)
                              J. C. Penney Company, Inc.
                            and Consolidated Subsidiaries

         Computation of Ratios of Available Income to Combined Fixed Charges
                       and Preferred Stock Dividend Requirement






                                              52 weeks               52 weeks
                                                ended                  ended
                                               Apr. 29,               May 1,
     ($ Millions)                               2000                  1999
                                              _________             _________

     Income from continuing operations        $      33             $     900
        (before income taxes, before
        capitalized interest, but after
        preferred stock dividend)

     Fixed charges

     Interest (including capitalized
     interest) on:

        Operating leases                            272                   225
        Short term debt                             109                   115
        Long term debt                              522                   558
        Capital leases                                1                     4
        Other, net                                    3                    (5)

                                              __________            __________
     Total fixed charges                            907                   897

     Preferred stock dividend, before taxes          35                    34

     Combined fixed charges and preferred     __________            __________
        stock dividend requirement                  942                   931

     Total available income                   $     975             $   1,831
                                              ==========             ==========

     Ratio of available income to combined
        fixed charges and preferred stock
        dividend requirement                        1.0                   2.0
                                              ==========            ==========




     The Company believes that, due to the seasonal nature of its business,
     ratios for a period of time other than a 52 week period are inappropriate.
EXHIBIT 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Petrol Industries, Inc. (the
"Company") on Form 10-QSB for the period ended September 30, 2005, as filed with
the Securities and Exchange commission on the date hereof (the "Report"), the
undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:

i.   The Report fully complies with the requirements of Section 13(a) or 15(d)
     of the Securities Exchange Act of 1934; and

ii.  The information contained in the Report fairly presents, in all material
     respects, the financial condition and results of operations of the Company.


Dated: December 9, 2005                    _______________
                                           David A. Taylor
                                           President and Chief Financial Officer


A signed original of this written statement required by Section 906 of the
Sarbanes-Oxley Act has been provided to Petrol Industries, Inc. and will be
retained by Petrol Industries, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.
Exhibit 23.1.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements filed by Osiris Therapeutics, Inc. on Form S-8
(Nos. 333-137953 and 333-137954) and Form S-3 (No. 333-148750) of our reports dated March 13, 2008 with respect to the audit
of the balance sheets of Osiris Therapeutics, Inc. as of December 31, 2007 and 2006, and the related statements of operations, changes in stockholders' equity (deficit), and cash flows
for each of the three years in the period ended December 31, 2007 and the audit of the effectiveness of internal control over financial reporting as of December 31, 2007, which reports
appear in the Annual Report on Form 10-K of Osiris Therapeutics, Inc. for the year ended December 31, 2007.

| | /s/STEGMAN & COMPANY
| | --------------------

Baltimore,
Maryland
March 14, 2008

---



QuickLinks
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; A Cooperative Research Partnerships for Biodefense and Emerging Infectious Diseases SEP 3.                    

*Date:*                         September 22, 2008.                    

*Time:*                         11 a.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6700B Rockledge Drive, 3257, Bethesda, MD 20817, (Telephone Conference Call).                    

*Contact Person:*                         Michelle M Timmerman, PhD, Scientific Review Officer, Scientific Review Program, NIH/NIAID/DHHS, Room 3147, 6700B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-451-4573,                         *timmermanm@niaid.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: August 26, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E8-20327 Filed 9-3-08; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Kevin Hogge, Chief Financial Officer of CRC Health Corporation (the Company), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that, to my knowledge:



| |  |  | the Annual Report on Form 10-K of the Company for the year ended December 31, 2007, as filed with the Securities and Exchange Commission (the
Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: April 7, 2008



|                                                                                                  
|--------------------------------------------------------------------------------------------------
|/s/    KEVIN
HOGGE                                                                                
|Kevin Hogge Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

A signed original of this written statement required by Section 906 has been provided to CRC
Health Corporation and will be retained by CRC Health Corporation and furnished to the Securities and Exchange Commission or its staff upon request.
Summary,waiver of  forfeiture prvsns-Non-Employ. Dir. Stck Comp. Plan, deceased



 Exhibit 10i-1 
  
 NORTHWEST NATURAL GAS COMPANY 
  
 Waiver of Forfeiture Provisions of Non-Employee Directors Stock Compensation Plan for Deceased Director 
  
 On December 16, 2004, the Board of Directors waived forfeiture provisions of the
Company’s Non-Employee Directors Stock Compensation Plan (“NEDSCP”) with respect to approximately 2,808 unvested shares of Company stock held in the account of Melody C. Teppola, a director of the Company who died on December 6, 2004.
Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS
ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

This certification is furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies this annual report on Form
10-K (the Form 10-K) for the year ended December 31, 2008 of Affinion Group, Inc. (the Issuer).

In connection with the Form 10-K, each of the undersigned, Nathaniel J. Lipman and Todd H. Siegel, certify, pursuant to 18 U.S.C. Section 1350, that to the best of their knowledge:

(i) the Form 10-K fully complies with the requirements of section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C.
78m(a) or 78o(d)); and

(ii) the information contained in the Form 10-K fairly presents, in all material respects, the
financial condition and results of operations of the Issuer as of the dates and for the periods indicated in the Form 10-K.



|                        |  |  |  |                        
|----------------------- |  |  |  | -----------------------
|/s/ Nathaniel J. Lipman |  |  |  | /s/ Todd H. Siegel     
|Nathaniel J. Lipman     |  |  |  | Todd H. Siegel         
|Chief Executive Officer |  |  |  | Chief Financial Officer
|February 26, 2010       |  |  |  | February 26, 2010